News | October 31, 2007

ACOG Announces Change In Colorectal Cancer Screening Recommendations

November 1, 2007 - The American College of Obstetricians and Gynecologists (ACOG) announced new recommendations emphasizing colonoscopy as the preferred method for colorectal cancer screening for both average-risk and high-risk women.

ACOG changed its colorectal cancer screening recommendations because colonoscopy allows for direct visualization of the entire colon surface, and it allows for removal of any precancerous polyps at the same time. Additionally, colonoscopy allows access to right-sided lesions-the main type of advanced colorectal cancer occurring in women-which are more likely to be missed by other screening methods. Previously, ACOG recommended that all women age 50 and older be screened for colorectal cancer by one of several methods, with no single method being preferred over another.

"Our message today is that colonoscopy is the gold standard when it comes to colorectal cancer screening. While we want ob-gyns to encourage this method, they should still discuss the advantages and limitations of the other screening options with their patients," said Carol L. Brown, M.D., immediate past vice chair of ACOG's Committee on Gynecologic Practice, which developed the recommendations. "The bottom line is we want women to get tested by whichever method they are most likely to accept and follow through with."

According to the Committee Opinion, ACOG does not recommend fecal DNA testing or computed tomography colonography (also known as "virtual colonoscopy") for screening outside the research setting, pending further data on their effectiveness.

For more information:

Related Content

FDA Approves Exablate Neuro for Tremor-Dominant Parkinson's Treatment
Technology | Focused Ultrasound Therapy | December 21, 2018
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
News | Radiation Dose Management | September 24, 2018
AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...